2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC18
  



  

  

  



  

  
Submitter : 
  

  
Dr. David Healy
  

  
Date & Time: 
  

  
09/02/2004 05:09:23
  



  

  
Organization : 
  

  
Cardiff University
  



  

  
Health Professional
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 In recent weeks, Pfizer have posted on the FDA website in connection with a forthcoming PDAC hearing an ad hominem attack on me.  This was apparently cleared before posting by FDA's chief counsel,Daniel Troy, who has had a prior close working relationship with Pfizer.  The attached material constitutes a preliminary response.